Detalhe da pesquisa
1.
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 21(2): 286-294, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481176
2.
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Clin Genitourin Cancer
; 21(5): 584-593, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414620
3.
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(6): 558-567, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36155169
4.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 20(5): e440-e452, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778337